首页> 外文期刊>International Journal of Cardiovascular and Thoracic Surgery >Thoracoplasty in the Management of Chronic Empyema: Experience of a Sub Saharan African Country
【24h】

Thoracoplasty in the Management of Chronic Empyema: Experience of a Sub Saharan African Country

机译:胸腔成形术治疗慢性脓胸:撒哈拉以南非洲国家的经验

获取原文
           

摘要

Introduction: The current main indication of thoracoplasty is empyema following or not lung resection, when the other surgical methods such as thoracic drainage, pleurostomy and/or pulmonary decortication have failed or are not useful. The authors report the role of thoracoplasty in the management of chronic empyema. Method: Between 2004 and 2015, eight male patients underwent thoracoplasty, in the Department of Thoracic Surgery at the University Hospital of Fann, Dakar, Senegal. The mean age was 40 years old. In all cases, the first step of the treatment was thoracic drainage with Heimlich valve in an ambulatory patient, associated with antibiotic according to the result of bacterial culture. In three patients, thoracostomy was indicated to control local infection before thoracoplasty. Results: Indications for thoracoplasty were refractory post resectionnal lung empyema in 6 cases and chronic primary apical empyema in 2 cases. Bronchopleural fistula was found in 5 patients. We performed three superior partial thoracoplasty, and five enlarged thoracoplasty. A myoplasty, using latissimus dorsi to fill the empyema space, was associated with thoracoplasty in five cases. Bronchopleural fistula cure consisted of a direct X form suture in two cases and of intercostal muscle apposition on the fistula in others ones. Partial scapulectomy, by resection of the inferior third part of the scapula was done in three patients. After a mean follow up of one year, no patient presented with persistence or recurrence of empyema. Then we concluded that they were healed. Conclusion: Thoracoplasty is an efficient procedure for the management of chronic empyema. So it is necessary for each team to established define criteria that will allow a patient to undergo thoracoplasty in order to do not use it for any desperate case of refractory chronic empyema.
机译:简介:当其他外科手术方法(如胸腔引流,胸膜切开术和/或肺去皮术)失败或无效时,胸腔成形术的当前主要适应症是脓胸后是否进行肺切除。作者报告了胸腔成形术在慢性脓胸治疗中的作用。方法:2004年至2015年,塞内加尔达喀尔市范恩大学医院胸外科的8例男性患者接受了胸廓成形术。平均年龄为40岁。在所有情况下,根据细菌培养的结果,治疗的第一步是在非卧床患者中使用Heimlich瓣膜进行胸腔引流,并与抗生素相关联。在三例患者中,胸廓切开术被指示在胸廓成形术之前控制局部感染。结果:胸廓成形术的指征为切除后难治性肺脓肿6例,慢性原发性根尖脓肿2例。 5例患者发现支气管胸膜瘘。我们进行了三个上部分胸腔成形术和五个扩大的胸腔成形术。五例使用胸背阔肌填充脓胸腔的肌成形术与胸廓成形术有关。支气管胸膜瘘的治愈包括2例直接X形缝合和另2例瘘管上肋间肌并存。在三名患者中,通过切除肩third骨的下部第三部分,进行了部分肩骨切除术。在平均随访一年后,没有患者出现脓胸持续或复发。然后我们得出结论,他们被治愈了。结论:胸廓成形术是治疗慢性脓胸的有效方法。因此,每个团队都有必要建立明确的标准,允许患者进行胸腔成形术,以免在绝望的难治性慢性脓胸病例中使用胸腔成形术。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号